{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:54:17Z","timestamp":1767974057708,"version":"3.49.0"},"reference-count":56,"publisher":"The Fukushima Society of Medical Science","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fukushima J. Med. Sci.","FJMS"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5387\/fms.59.15","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T23:02:55Z","timestamp":1373410975000},"page":"15-26","source":"Crossref","is-referenced-by-count":49,"title":["HENOCH-SCH^|^Ouml;NLEIN PURPURA NEPHRITIS IN CHILDHOOD: PATHOGENESIS, PROGNOSTIC FACTORS AND TREATMENT"],"prefix":"10.5387","volume":"59","author":[{"given":"YUKIHIKO","family":"KAWASAKI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ATSUSHI","family":"ONO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINICHIRO","family":"OHARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUICHI","family":"SUZUKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUHIDE","family":"SUYAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUNZO","family":"SUZUKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MITSUAKI","family":"HOSOYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3342","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, <i>et al.<\/i> The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum, <b>33<\/b>(8): 1114-1121, 1990.","DOI":"10.1002\/art.1780330809"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Saulsbury FT. Epidermiology of Henoch-Schonlein purpura. Cleve Clin J Med, <b>69<\/b>: 187-189, 2002.","DOI":"10.3949\/ccjm.69.Suppl_2.SII87"},{"key":"3","unstructured":"3. Bunchman TE, Mauer SM, Sibley RK, Vernier RL. Anaphylactoid purpura: characteristics of 16 patients who progressed to renal failure. Pediatr Nephrol, <b>2<\/b>: 393-397, 1988."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C. Prognosis of Henoch-Sch&ouml;nlein nephritis in children. Br Med J, <b>2<\/b>: 11-14, 1977.","DOI":"10.1136\/bmj.2.6078.11"},{"key":"5","unstructured":"5. Yoshikawa N, Ito H, Yoshiya K, Nakahara C, Yoshiara S, Hasegawa O, Matsuyama S, Matsuo T. Henoch-Schoenlein nephritis and IgA nephropathy in children: a comparison of clinical course. Clin Nephrol, <b>27<\/b>: 233-237, 1987."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet, <b>360<\/b>: 1197-1202, 2002.","DOI":"10.1016\/S0140-6736(02)11279-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Stewart M, Savage JM, Bell B, McCord B. Long term renal prognosis of Henoch-Sch&ouml;nlein purpura in unselected childhood population. Eur J Pediatr, <b>147<\/b>: 113-115, 1988.","DOI":"10.1007\/BF00442205"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nielsen HE. Epidemiology of Schonlein-Henoch Purpura. Acu Pathol Scand, <b>77<\/b>: 125-131, 1988.","DOI":"10.1111\/j.1651-2227.1988.tb10610.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kawasaki Y, Suyama K, Yugeta E, Katayose M, Suzuki S, Sakuma H, <i>et al.<\/i> The incidence and severity of Henoch-Sch&ouml;nlein purpura nephritis over a 22-year period in Fukushima Prefecture, Japan. Int Urol Nephrol, <b>42<\/b>: 1023-1029, 2010.","DOI":"10.1007\/s11255-009-9701-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Vogler C, Eliason SC, Wood EG. Glomerular membranopathy in children with IgA nephropathy and Henoch-Schoenlein purpura. Pediatr Dev Pathol, <b>2<\/b>: 227-235, 1999.","DOI":"10.1007\/s100249900118"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kerr MA. The structure and function of human IgA. Biochem J, <b>271<\/b>: 285-296, 1990.","DOI":"10.1042\/bj2710285"},{"key":"12","unstructured":"12. Yoo EM, Morrison SL. IgA: an immune glycoprotein. Clin Immunol, <b>116<\/b>: 3-10, 2005."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Jones CL, Powell HR, Kincaid-Smith P, Roberton DM. Polymeric IgA and immune complex concentrations in IgA-related renal disease. Kidney Int, <b>38<\/b>: 323-331, 1990.","DOI":"10.1038\/ki.1990.204"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Allen AC, Willis FR, Beattie TJ, Feehally J. Abnormal IgA glycosylation in Henoch-Schoenlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant, <b>13<\/b>: 930-934, 1998.","DOI":"10.1093\/ndt\/13.4.930"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Egmond M, Damen CA, Spriel AB, Vidarsson G, Garderen E, Winkel JGJ. IgA and IgA Fc receptor. TRENDS in immunology, <b>22<\/b>: 205-211, 2001.","DOI":"10.1016\/S1471-4906(01)01873-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Moja P, Quesnel A, Resseguier V, Lambert C, Freycon F, Berthoux F, <i>et al.<\/i> Is there IgA from gut mucosal origin in the serum of children with Henoch-Schoenlein purpura? Clin Immunol Immunopathol, <b>86<\/b>: 290-297, 1998.","DOI":"10.1006\/clin.1997.4493"},{"key":"17","unstructured":"17. Silva FG. IgA nephropathy and Henoch-Schoenlein Syndrome. In Jennette JC, Olson JL, Schwartz MM, Silva FG(eds): Heptinstall's Pathology of the Kidney. 15<sup>th<\/sup> ed. Lippincott-Raven, Philadelphia, 479-540, 1998."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Allen A, Harper S, Feehally J. Origin and structure of pathogenic IgA in IgA nephropathy. Biochem Soc Trans, <b>25<\/b>: 486-490, 1997.","DOI":"10.1042\/bst0250486"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jones CL, Powell HR, Kincaid-Smith P, Roberton DM. Polymeric IgA and immune complex concentrations in IgA-related renal disease. Kidney Int, <b>38<\/b>: 323-331, 1990.","DOI":"10.1038\/ki.1990.204"},{"key":"20","unstructured":"20. Coppo R, Basolo B, Bulzomi MR, Roccatello D, Carbonara AO, Barbiano di Belgiojoso G, <i>et al.<\/i> IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schoenlein purpura nephritis. Clin Exp Immunol, <b>57<\/b>: 583-590, 1984."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Levinsky RJ, Barratt TM. IgA immune complexes in Henoch-Schoenlein purpura. Lancet, <b>24<\/b>: 1100-1103, 1979.","DOI":"10.1016\/S0140-6736(79)92505-4"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Leu KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, <i>et al.<\/i> Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schoenlein purpura. Pediatr Nephrol, <b>22<\/b>: 2067-2072, 2007.","DOI":"10.1007\/s00467-007-0623-y"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Oortwijn BD, Eijgenraam JW, Rastaldi MP, Roos A, Daha MR, van Kooten C. The role of secretary IgA and complement in IgA nephropathy. Semin Nephrol, <b>28<\/b>: 58-65, 2008.","DOI":"10.1016\/j.semnephrol.2007.10.007"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M. Complement activation through the lectin pathway in patients with Henoch-Sch&ouml;nlein purpura nephritis. Am J Kidney Dis, <b>35<\/b>: 401-407, 2000.","DOI":"10.1016\/S0272-6386(00)70192-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hisano S, Matsushita M, Fujita T, Iwasaki H. Activation of the lectin complement pathway in Henoch-Sch&ouml;nlein purpura nephritis. Am J Kidney Dis, <b>45<\/b>: 295-302, 2005.","DOI":"10.1053\/j.ajkd.2004.10.020"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Moura IC, Benhamou M, Launay P, Vrtovsnik F, Blank U, Monteiro RC. The glomerular response to IgA deposition in IgA nephropathy. Semin Nephrol, <b>28<\/b>: 88-95, 2008.","DOI":"10.1016\/j.semnephrol.2007.10.010"},{"key":"27","unstructured":"27. Kawsaki Y, Suzuki J, Nemoto K, Nozawa R, Suzuki S, Suzuki H. Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol, <b>60<\/b>: 153-160, 2003."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Fujieda M, Oishi N, Naruse K, Hashizume M, Nishiya K, Kurashige T, Ito K. Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schoenlein purpura. Arch Dis Child, <b>78<\/b>: 240-244, 1998.","DOI":"10.1136\/adc.78.3.240"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kawasaki Y, Suzuki J, Nozawa R, Sakai N, Tannji M, Isome M, <i>et al.<\/i> FB21, a monoclonal antibody that reacts with a sialic-acid-dependent carbohydrate epitope, is a marker for glomerular endothelial cell injury. Am J Kidney Dis, <b>44<\/b>: 239-249, 2004.","DOI":"10.1053\/j.ajkd.2004.04.028"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kawasaki Y, Suzuki H, Henoch-Schoenlein Nephritis. In Geary DF, Schaefer F (eds): Comprehensive Pediatric Nephrology, Mosby, Elsevier. pp. 343-351, 2008.","DOI":"10.1016\/B978-0-323-04883-5.50029-5"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Algoet C, Proesmans W. Renal biopsy 2-9 years after Henoch Sch&ouml;nlein purpura. Pediatr Nephrol, <b>18<\/b>: 471-473, 2003.","DOI":"10.1007\/s00467-003-1132-2"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Schoenlein nephritis. Lancet, <b>339<\/b>: 280-282, 1992.","DOI":"10.1016\/0140-6736(92)91341-5"},{"key":"33","unstructured":"33. Meadow SR, Glasgow EF, White RH, Moncrieff MW, Cameron JS, Ogg CS. Schoenlein-Henoch nephritis. Q J Med, <b>41<\/b>: 241-245, 1972."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kawasaki Y, Imaizumi T, Matsuura H, Ohara S, Takano K, Suyama K, <i>et al.<\/i> Renal expression of alpha-smooth muscle actin and c-Met in children with Henoch-Sch&ouml;nlein purpura nephritis. Pediatr Nephrol, <b>23<\/b>: 913-919, 2008.","DOI":"10.1007\/s00467-008-0749-6"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36. Kawasaki Y, Ohara S, Abe Y, Watanabe M, Suyama K, Sato M, Hashimoto K, Hosoya M. The role of serum myeloid-related protein 8\/14 complex in Henoch-Schoenlein purpura nephritis, Pediatr Nephrol, <b>27<\/b>: 65-71, 2012.","DOI":"10.1007\/s00467-011-1937-3"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37. Reif S, Jain A Santiago J Rossi T. Protein-losing enteropathy as a manifestation of Henoch-Schoenlein purpura. Acuta Paediatr Scand, <b>80<\/b>: 482-485, 1991.","DOI":"10.1111\/j.1651-2227.1991.tb11888.x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38. Cull DL, Rosario V, Lally KP, Ratner I, Mahour GH. Surgical implications of Henoch-Schoenlein purpura. J Pediatr Surg, <b>25<\/b>: 741-743, 1990.","DOI":"10.1016\/S0022-3468(05)80009-0"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39. Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schoenlein-Henoch purpura nephritis. Pediatr Nephrol, <b>12<\/b>: 238-243, 1998.","DOI":"10.1007\/s004670050446"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40. Mollica F, Li Volti S, Garozzo R, Russo G. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr, <b>151<\/b>: 140-144, 1992.","DOI":"10.1007\/BF01958961"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41. Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schoenlein nephritis. Pediatrics, <b>111<\/b>: 785-789, 2003.","DOI":"10.1542\/peds.111.4.785"},{"key":"41","unstructured":"42. Oner A, Tinaztepe K, Erdogan O. The effect of triple therapy on rapidly progressive type of Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy. Clin Nephrol, <b>49<\/b>: 9-14, 1998."},{"key":"42","unstructured":"43. Bergstein J, Leiser J, Andreoli SP. Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy. Clin Nephrol, <b>49<\/b>: 9-14, 1998."},{"key":"43","doi-asserted-by":"crossref","unstructured":"44. Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N. Multiple combined therapy for severe Henoch-Schoenlein nephritis in children. Pediatr Nephrol, <b>12<\/b>: 244-248, 1998.","DOI":"10.1007\/s004670050447"},{"key":"44","doi-asserted-by":"crossref","unstructured":"45. Flynn JT, Smoyer WE, Bunchman TE, Kershaw DB, Sedman A. Treatment of Henoch-Schoenlein purpura Glomerulonephritis in Children with High-Dose Corticosteroids plus Oral Cyclophosphamide. Am J Nephrol, <b>21<\/b>: 128-133, 2001.","DOI":"10.1159\/000046235"},{"key":"45","unstructured":"46. Kawasaki Y, Suzuki J, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study. Nephrol Dial Transplant, <b>19<\/b>: 858-864, 2004."},{"key":"46","unstructured":"47. Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Jeong HJ. Henoch-Sch&ouml;nlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment. Scand J Rheumatol, <b>34<\/b>: 392-395, 2005."},{"key":"47","doi-asserted-by":"crossref","unstructured":"48. Kawasaki Y, Suyama K, Hashimoto K, Hosoya M. Methylprednisolone pulse plus mizoribine in children with Henoch-Schoenlein purpura nephritis. Clin Rheumatol, <b>30<\/b>: 529-535, 2011","DOI":"10.1007\/s10067-010-1572-6"},{"key":"48","doi-asserted-by":"crossref","unstructured":"49. Ninchoji T, Kaito H, Nozu K, Hashimura Y, Kanda K, Kamioka I, Shima Y, Hamahira K, Nakanishi K, Tanaka R, Yoshikawa N, Iijima K, Matsuo M. Treatment strategies for Henoch-Schoenlein purpura nephritis by histological and clinical severity. Pediatr Nephrol, <b>26<\/b>: 563-569, 2011.","DOI":"10.1007\/s00467-010-1741-5"},{"key":"49","doi-asserted-by":"crossref","unstructured":"50. Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioka T, Khono M. Plasmapheresis as the sole therapy for rapidly progressive Schoenlein-Henoch purpura nephritis in children. Am J Kidney Dis, <b>33<\/b>: 427-433, 1999.","DOI":"10.1016\/S0272-6386(99)70178-2"},{"key":"50","doi-asserted-by":"crossref","unstructured":"51. Kawasaki Y, Suzuki J, Murai M, Takahashi A, Isome M, Nozawa R, <i>et al.<\/i> Plasmapheresis therapy for rapidly progressive Henoch-Schoenlein nephritis. Pediatr Nephrol, <b>19<\/b>: 920-923, 2004.","DOI":"10.1007\/s00467-004-1514-0"},{"key":"51","unstructured":"52. Heldrich FJ, Minkin S, Gatdula CI. Intravenous immunoglobulin in Henoch-Schoenlein purpura: A case study. Md Med J, <b>42<\/b>: 577-579, 1993."},{"key":"52","doi-asserted-by":"crossref","unstructured":"53. Suguyama H, Watanabe N, Onoda T, Kikumoto Y, Yamamoto M, Maeta M, <i>et al.<\/i> Successful treatment of progressive Henoch-Schoenlein purpura nephritis with tonsillectomy and steroid pulse therapy. Intern Med, <b>44<\/b>: 611-615, 2005.","DOI":"10.2169\/internalmedicine.44.611"},{"key":"53","doi-asserted-by":"crossref","unstructured":"54. Kawasaki Y, Suyama K, Matsumoto A, Takano K, Hashimoto K, Suzuki S, <i>et al.<\/i> Efficacy of tonsillectomy plus methylprednisolone pulse therapy for a child with Henoch-Schoenlein purpura nephritis. Tohoku J Exp Med, <b>211<\/b>: 291-295, 2007.","DOI":"10.1620\/tjem.211.291"},{"key":"54","doi-asserted-by":"crossref","unstructured":"55. Ohara S, Kawasaki Y, Matsuura H, Oikawa T, Suyama K, Hosoya M. Successful therapy with tonsillectomy for severe ISKDC grade IV Henoch-Schoenlein purpura nephritis and persistent nephrotic syndrome. Clin Exp Nephrol, <b>15<\/b>: 749-753, 2011.","DOI":"10.1007\/s10157-011-0463-8"},{"key":"55","unstructured":"56. Meulders Q, Pirson Y, Cosyns JP, Squifflet JP, van Ypersele de Strihou C. Course of Henoch-Schoenlein nephritis after renal transplantation: Report on ten patients and review of the literature. Transplantation, <b>58<\/b>: 1179-1186, 1994."},{"key":"56","doi-asserted-by":"crossref","unstructured":"57. Ramos EL. Recurrent diseases in the renal allograft. J Am Soc Nephrol, <b>2<\/b>: 109-121, 1991.","DOI":"10.1681\/ASN.V22109"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:27:41Z","timestamp":1646008061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/59\/1\/59_15\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.59.15","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}